This week, a recent study reported an unconventional use for semaglutide, which is the active component in the popular obesity medication Wegovy. This study suggests that the drug may be helpful for individuals dealing with alcohol use disorder. The research showed that people taking semaglutide for weight loss also had significant reductions in symptoms of …
Coffee: The Truth About Your Favorite Morning Blend Coffee has been a topic of controversy in the health world, with medical experts offering conflicting opinions on its benefits and risks. Despite this, coffee remains America’s drink of choice, favored even over water, according to the National Coffee Association. But what exactly are the potential health …
Perth Mom Reveals Incredible Weight Loss Transformation After Breaking Bad Habit Perth, Australia – Jodie Marah, a busy mom from Perth, recently shared her remarkable weight loss journey after making a significant lifestyle change. Just a year ago, Jodie reached her heaviest weight of 176 pounds and was wearing a size 16 for the first …
New Scientific Study Suggests Low-Isoleucine Diet Could Prolong Lifespan and Improve Health Outcomes in Mice Research conducted by the University of Wisconsin-Madison has found that reducing the intake of the amino acid isoleucine in diets could have significant health benefits for mice. The study revealed that a low-isoleucine diet led to longer lifespans, leaner bodies, …
New Research Shows Belly Fat May Increase Alzheimer’s Risk 15 Years Before Symptoms New findings from the Radiological Society of North America (RSNA) suggest that even though it might not be visible, deep belly fat could be a hidden indicator of potential Alzheimer’s risk. According to the research released by the RSNA, visceral fat, which …
Discoveries Revealed: How Excess Midlife Abdominal Fat Is Linked to Alzheimer’s Onset Recent findings to be presented at the annual meeting of the Radiological Society of North America (RSNA) shed light on the correlation between elevated levels of visceral abdominal fat in middle-aged individuals and the heightened probability of developing Alzheimer’s disease. In-depth research, which …
Health By Taylor Knight Published Nov. 12, 2023, 3:29 p.m. ET The obesity drug Wegovy can reduce the risk of severe heart problems by 20%, a pivotal study finds, paving the way for applications far beyond weight loss. “It moves from a kind of therapy that reduces body weight to a therapy that reduces cardiovascular events,” said …
Novo Nordisk’s obesity drug, Wegovy, has been hailed for its milestone findings in a landmark cardiovascular trial that demonstrates its ability to reduce the risk of heart attacks. The trial, called Select, showcased how Wegovy not only leads to weight loss but also significantly reduces the likelihood of major heart problems such as heart attacks, …
Researchers have discovered that GDF15, a hormone known to suppress appetite, also enhances insulin sensitivity in rodents, potentially leading to new diabetes treatments. While GDF15 is connected to various physiological states, its role in human health and its potential benefits in improving insulin sensitivity require further investigation. The hormone reduces appetite in animals and occurs …
Summary: Research indicates a strong correlation between a high-sugar diet, often linked to obesity, and the onset of insulin resistance in the brain, raising the risk of neurodegenerative conditions like Alzheimer’s. This study has uncovered that the aforementioned insulin resistance impedes the capacity of glial cells to effectively remove neuronal debris, a critical process necessary …